Research Needed to Understand Impact of Low-Dose Radiation
Estimated $100 million needed annually for the next 10 to 15 years to conduct epidemiological, biological research
Estimated $100 million needed annually for the next 10 to 15 years to conduct epidemiological, biological research
Previous research suggested that allopurinol, a xanthine oxidase inhibitor, prevents the formation of oxygen-free radicals that may contribute to contrast nephropathy.
New findings challenge recommendations from the European Association of Urology.
Some patients with a negative mpMRI while on prostate cancer active surveillance may be able to defer biopsy, according to investigators.
Study confirms the care gap in bone health management and fracture prevention among older men with prostate cancer receiving androgen deprivation therapy.
Joint American Urological Association and Society of Urologic Oncology guidelines recommend deescalation of surveillance for low-grade Ta NMIBC.
In patients with high-risk prostate cancer, negative PSMA PET/CT does not permit PLND avoidance, investigators cautioned.
Racial disparity in the use of emerging diagnostic technologies may widen gaps in cancer treatment and outcomes, according to investigators.
NephroScan is a sterile, single-dose kit for the preparation of technetium Tc 99m succimer injection for intravenous use.
On univariate analysis, positive vs negative MRI findings were significantly associated with a 3.1-fold higher risk for cancer-specific death, according to investigators.